The latest industry happenings from the past month, all in one place.
Emer Cooke has begun her mandate as Executive Director of the European Medicines Agency November 16, 2020.
Langland is proud to announce the appointment of Angela Rochelle as Account Director, Head of Diversity Initiatives in Clinical Trials.
WCG announced the appointment of two new independent members to its Board of Directors: Dr. Kavita Patel, and Pascale Witz.
Atlantic Research Group has named Dr. Ed Schnipper, Dr. Mark Rodger Stein, and Dr. Angela Genge as members of its new Scientific Advisory Board.
Pivotal announced that it has been contracted by Checkpoint Therapeutics Inc. to provide services in Europe for its upcoming study of its Programmed Death-Ligand 1 inhibitor, cosibelimab, in cutaneous squamous cell carcinoma patients.
Rho announced the Rho Federal Systems Division, Inc. was awarded a contract from the Biomedical Advanced Research and Development Authority.
Certara announced the opening of a new office in Shanghai’s Pudong District.
SGS Life Sciences announced the recruitment of the first participants in the U.S. to take part in a multinational clinical trial of a potential drug candidate for those suffering with COVID-19 related respiratory failure.
Almac Group has welcomed news from Pfizer, and its German partner, BioNTech, that through the use of its TempEZ platform, their potential COVID-19 vaccine showed better than 90% efficacy in their pivotal Phase III trial.
CCT announced it will be conducting trials in Phoenix for AstraZeneca’s AZD1222 COVID-19 vaccine.
Montrium announced the release of a Success Story with technology partner Pharmascience.
Syneos Health announced they have been named to the Forbes 2020 list of World’s Best Employers.
Accelerated Enrollment Solutions, a business of PPD, Inc., has been named the winner of the 2020 Site Tank Award by the Society for Clinical Research Sites.
Shimmer Research announced that its Verisense wearable sensing platform has been awarded the 2020 Best of Sensors: Most Innovative Product Award in the Wearables category.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.